GlassScriptPhysician profile
Patrick Michael Looser
NPI 1508165291
$8,870.60
in general payments reported to CMS, 2019-2025
43 companies · $1,213 in 2025
The $1,213 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,566 · 2020: $2,398 · 2021: $709 · 2022: $744 · 2023: $1,101 · 2024: $1,141 · 2025: $1,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,454.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,057.41 | 2019-2025 | Amplatzer Amulet, Aveir, Jot Dx |
| E.R. Squibb & Sons, L.L.C. | $616.64 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $540.41 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $402.48 | 2019-2025 | |
| Edwards Lifesciences Corporation | $386.71 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.33 | 2019-2025 | Jardiance |
| Amgen INC. | $366.73 | 2019-2025 | Repatha |
| Philips North America LLC | $318.48 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions, (5091) Amb Mon & Diag Und |
| Astrazeneca Pharmaceuticals LP | $288.07 | 2019-2024 | Farxiga |
| Boston Scientific Corporation | $224.63 | 2019-2025 | Avvigo Guidance System, Bodyguardian |
| Janssen Pharmaceuticals, INC | $195.32 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $151.39 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Endologix LLC | $150.00 | 2025 | Torus Stent Graft System, Endocross Device |
| Pfizer INC. | $145.73 | 2019-2024 | |
| Livanova USA, INC. | $134.28 | 2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $133.19 | 2022-2023 | Diamondback Coronary |
| Medtronic Vascular, INC. | $132.09 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $126.10 | 2019-2021 | |
| Irhythm Technologies, INC. | $119.44 | 2023-2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| Esperion Therapeutics, INC. | $114.68 | 2021-2023 | Nexletol |
| Astellas Pharma US INC | $82.13 | 2019-2021 | |
| Cvrx, INC. | $77.91 | 2023-2024 | Barostim Neo System |
| Shockwave Medical, INC | $63.84 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $62.87 | 2022-2024 | Onpattro |
| Penumbra, INC. | $57.42 | 2019 | |
| Cardiva Medical, INC. | $54.54 | 2025 | Savvywire, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Actelion Pharmaceuticals US, INC. | $54.43 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Kiniksa Pharmaceuticals, LTD. | $47.65 | 2022-2023 | Arcalyst |
| Medtronic, INC. | $46.87 | 2021-2024 | Tyrx |
| Teleflex LLC | $43.51 | 2023 | Langston |
| Kiniksa Pharmaceuticals International, Plc | $42.30 | 2024 | Arcalyst |
| Vital Connect, INC | $31.98 | 2024 | Vitalpatch Rtm |
| Terumo Medical Corporation | $31.50 | 2020-2024 | Tr Band, Glidewire, Glidesheath Slender |
| Heartflow, INC. | $31.45 | 2019 | |
| Lantheus Medical Imaging, INC. | $22.60 | 2022 | |
| Cardinal Health 200 LLC | $22.13 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.94 | 2025 | |
| Biotronik INC. | $20.93 | 2024 | |
| Scpharmaceuticals INC. | $17.70 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $16.85 | 2019 | |
| Glaxosmithkline, LLC. | $16.32 | 2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $12.51 | 2021 | |
| Atricure, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Looser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.